In addition to providing allergic patients with a more convenient, needle-free alternative to auto-injectors currently on the market, an epinephrine product that provides greater flexibility in ...

Two adults living in one of the apartments were treated for smoke inhalation at the scene by AMR ambulance personnel, then transported to a local hospital for additional treatment. The severity of ...

pictured here, as our thoughts are with the loved ones they left behind to fight their cause. Died due to inhalation of fire fumes and heat. Died due to inhalation of fire fumes.

As a result, the U.S. Food and Drug Administration (FDA) is no longer enjoined from issuing final approval of Liquidia’s New Drug Application (NDA) for YUTREPIA™ (treprostinil) inhalation powder.

Epinephrine inhalation is now widely used to provide bronchodilator therapy for patients with chronic obstructive pulmonary emphysema. In this study a variety of cardiorespiratory effects following ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed ...

Center for Policy and Research in Emergency Medicine, Oregon Health and Science University, Portland (M.H., M.D.). Sunnybrook Center for Prehospital Medicine, Department of Family and Community ...

An international group of researchers has successfully documented the first clear evidence of long-hypothesized catalysts involved in aerosol formation. Eighty-five percent of Earth’s atmosphere is ...

Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase II drugs for Asthma have a 27% phase transition success rate (PTSR ...